11/19/2024
3:20 PM | Seres Therapeutics (Issuer)
von Moltke Lisa (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/19/2024
3:21 PM | DesRosier Thomas (Reporting)
Seres Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/13/2024
9:30 AM | Seres Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
11/13/2024
7:05 AM | Seres Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/29/2024
5:33 PM | Seres Therapeutics (Issuer)
von Moltke Lisa (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/29/2024
5:23 PM | Seres Therapeutics (Issuer)
Young Teresa L. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/29/2024
5:24 PM | Seres Therapeutics (Issuer)
Shaff Eric D. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
|
10/29/2024
5:26 PM | DesRosier Thomas (Reporting)
Seres Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/29/2024
5:27 PM | Henn Matthew R. (Reporting)
Seres Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/14/2024
11:15 PM | Seres Therapeutics (Filer)
| Form EFFECT | |
10/11/2024
3:34 PM | Seres Therapeutics (Filer)
| Form 424B3 | |
10/02/2024
7:15 AM | NESTLE SA (Reporting)
Seres Therapeutics (Issuer)
Societe des Produits Nestle S.A. (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
10/02/2024
7:15 AM | NESTLE SA (Filed by)
Seres Therapeutics (Subject)
| Form SC 13D/A | |
10/01/2024
3:46 PM | Seres Therapeutics (Filer)
| Form S-3
Registration statement under Securities Act of 1933 | |
09/26/2024
3:13 PM | Seres Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/12/2024
7:30 AM | Seres Therapeutics (Filer)
| Form DEFA14A | |
09/12/2024
6:05 AM | Seres Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/26/2024
3:36 PM | Seres Therapeutics (Filer)
| Form DEFM14A | |
08/19/2024
4:38 PM | Seres Therapeutics (Issuer)
Shaff Eric D. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/19/2024
4:42 PM | Henn Matthew R. (Reporting)
Seres Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/19/2024
4:45 PM | Seres Therapeutics (Issuer)
von Moltke Lisa (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/19/2024
4:48 PM | DesRosier Thomas (Reporting)
Seres Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/19/2024
4:29 PM | Ege David S. (Reporting)
Seres Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/19/2024
4:36 PM | Seres Therapeutics (Issuer)
Young Teresa L. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/15/2024
5:52 AM | Seres Therapeutics (Filer)
| Form PREM14A | |
08/15/2024
5:05 AM | Seres Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/13/2024
4:21 PM | Seres Therapeutics (Filer)
| Form DEFA14A | |
08/13/2024
9:38 AM | Seres Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
08/13/2024
6:05 AM | Seres Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/13/2024
6:08 AM | Seres Therapeutics (Filer)
| Form DEFA14A | |
08/07/2024
7:38 AM | Seres Therapeutics (Filer)
| Form DEFA14A | |
08/06/2024
7:39 PM | Seres Therapeutics (Filer)
| Form DEFA14A | |
08/06/2024
4:27 PM | Seres Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/06/2024
4:28 PM | Seres Therapeutics (Filer)
| Form DEFA14A | |
08/06/2024
4:28 PM | Seres Therapeutics (Filer)
| Form DEFA14A | |
08/06/2024
3:15 PM | Seres Therapeutics (Issuer)
Young Teresa L. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/06/2024
6:39 AM | Seres Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/06/2024
6:41 AM | Seres Therapeutics (Filer)
| Form DEFA14A | |
05/17/2024
7:16 PM | Ege David S. (Reporting)
Seres Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/17/2024
7:17 PM | Henn Matthew R. (Reporting)
Seres Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/17/2024
7:18 PM | Seres Therapeutics (Issuer)
Young Teresa L. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
Trump won. Buy this coin now. (Ad) Juan Villaverde called the top and bottom of every crypto bull market since 2012.
He believes Bitcoin will go to $150,000 — or more.
But there’s one coin he thinks could go even higher. This could be his favorite coin. |
05/17/2024
7:18 PM | Seres Therapeutics (Issuer)
Shaff Eric D. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/17/2024
7:23 PM | Seres Therapeutics (Issuer)
von Moltke Lisa (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/17/2024
7:14 PM | DesRosier Thomas (Reporting)
Seres Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/08/2024
9:00 AM | Seres Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
05/08/2024
6:05 AM | Seres Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/07/2024
4:18 PM | Seres Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/23/2024
6:00 AM | Seres Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/08/2024
3:45 PM | Berenson Stephen (Reporting)
Seres Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/08/2024
3:45 PM | Ausiello Dennis A (Reporting)
Seres Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/08/2024
3:45 PM | Dere Willard H (Reporting)
Seres Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/08/2024
3:45 PM | Fraser Claire (Reporting)
Seres Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/08/2024
3:45 PM | Biondi Paul (Reporting)
Seres Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/08/2024
3:45 PM | Kender Richard N (Reporting)
Seres Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/08/2024
3:45 PM | Graves Kurt (Reporting)
Seres Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/08/2024
3:30 PM | Seres Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/05/2024
11:21 AM | BlackRock Inc. (Filed by)
Seres Therapeutics (Subject)
| Form SC 13G/A | |
03/27/2024
3:20 PM | Seres Therapeutics (Issuer)
Thorell Marella (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/05/2024
9:01 AM | Seres Therapeutics (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
03/05/2024
9:13 AM | Seres Therapeutics (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
03/05/2024
9:18 AM | Seres Therapeutics (Filer)
| Form DEF 14A | |
03/05/2024
6:05 AM | Seres Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/26/2024
6:06 AM | Seres Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/16/2024
8:48 PM | DesRosier Thomas (Reporting)
Seres Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/16/2024
8:42 PM | Seres Therapeutics (Issuer)
Shaff Eric D. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/16/2024
8:21 PM | Seres Therapeutics (Issuer)
von Moltke Lisa (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/16/2024
8:29 PM | Seres Therapeutics (Issuer)
Young Teresa L. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/16/2024
8:31 PM | Henn Matthew R. (Reporting)
Seres Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/16/2024
8:13 PM | Arkowitz David (Reporting)
Seres Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/16/2024
8:15 PM | Ege David S. (Reporting)
Seres Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/12/2024
11:23 AM | JANUS HENDERSON GROUP PLC (Filed by)
Seres Therapeutics (Subject)
| Form SC 13G/A | |
02/09/2024
8:49 AM | FMR LLC (Filed by)
Seres Therapeutics (Subject)
| Form SC 13G/A | |
01/30/2024
3:01 PM | Seres Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/29/2024
4:25 PM | BlackRock Inc. (Filed by)
Seres Therapeutics (Subject)
| Form SC 13G | |
01/10/2024
6:00 AM | Seres Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/09/2024
6:05 AM | Seres Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
